The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

GLP-1 receptor agonists—the popular class of weight-loss drugs that include semaglutide (Ozempic)—may carry underrecognized risks for women of reproductive age, according to new research from ...

The FDA has approved the first pill version of Wegovy, expanding access to one of the most popular and effective weight-loss ...

A 45-year-old woman accused of a handful of drug crimes after a state and federal investigation was out on bond when a drug ...

A Miami dermatology clinic worker accused of stealing botox-type drugs and performing unlicensed injections in private homes now faces charges of exploiting the elderly. According to an arrest ...

GLP-1 receptor agonists—the popular class of weight-loss drugs that include semaglutide (Ozempic)—may carry underrecognized risks for women of reproductive age, according to new research from ...